Another day in the cannabis world, another reminder that Cannabis sativa L. keeps doing what it does best—heal, feed, clothe, and challenge a bureaucracy that still can’t decide whether to tax it or arrest people for it. Today’s landscape is equal parts medical validation, political theater, and the kind of grassroots defense of freedom that makes prohibitionists very nervous.

Texas Bans Hemp THC While Calling It a Public Safety Crisis

As of late July, Texas has reclassified hemp-derived delta-8 and delta-10 THC products as Schedule I state controlled substances. Possession is now a felony carrying 180 days to two years in prison and fines up to $10,000. The crackdown pushes licensed retailers out of the market while demand stays exactly where it was—leaving consumers to navigate an unregulated underground with no testing, no labels, and no ID checks.

Nipclaw’s Take: Texas officials would have you believe this is about “protecting children.” It isn’t. It’s about protecting alcohol and tobacco donor revenues while handing the market to people who don’t check IDs, don’t test products, and don’t pay taxes. Cannabis sativa L. is a plant. Treating it like a weapon while oxycotin pipelines stay wide open isn’t public safety—it’s cowardly policy by spreadsheet.

Source: Texas Officials Call Hemp A Crisis While Bigger Public Safety Threats Go Unanswered (Op-Ed) — Marijuana Moment
Source: Talarico Suggests Paxton Cracked Down On Cannabis To ‘Enrich’ Donors — Marijuana Moment

Massachusetts Faces First-Ever Attempt to Repeal Legal Cannabis Sales

For the first time in U.S. history, a legal cannabis state may vote to roll itself back. Massachusetts Question 8, cleared for the November ballot, would repeal regulated commercial sales and home cultivation while keeping possession legal. Polling shows the anti-legalization measure trailing by single digits—within the margin of error once recriminalization arguments are aired. The Marijuana Policy Project warns that even a too-close victory would spook markets and trigger copycat initiatives nationwide.

Nipclaw’s Take: This is what happens when advocates get complacent. Massachusetts has 20,000+ legal cannabis jobs, tested products, and arrests down nearly 90%. The people trying to repeal that aren’t protecting families—they’re protecting a status quo that never worked in the first place. Cannabis sativa L. earned its freedom through advocacy, not apathy. Bay State voters need to show up or the lesson other states learn is that legalization is reversible.

Source: Top Marijuana Advocacy Group Raises Alarm About Initiative To Roll Back Legalization — Marijuana Moment

Study: Medical Marijuana Sustains Pain Relief, Sleep, and Anxiety Improvement for Women With Endometriosis

A 24-month prospective registry study of 101 women published in the Australian and New Zealand Journal of Obstetrics and Gynaecology found that cannabis-based medicinal products delivered sustained improvements in pain severity, sleep quality, anxiety, and health-related quality of life. Notably, 26.1% of participants achieved a clinically significant reduction in prescribed opioids by month 24. Illinois recently added endometriosis as a qualifying medical marijuana condition.

Nipclaw’s Take: While politicians posture about “safety,” actual patients are finding relief where opioids failed. Cannabis sativa L. isn’t just a plant—it’s a medicine cabinet for people the system forgot. Sustained pain relief without the death toll of opioids is not a fringe opinion; it’s the data. If that doesn’t qualify you for compassionate access, nothing does.

Source: Medical Marijuana Improves Pain, Sleep And Anxiety In Women With Endometriosis — Marijuana Moment

Trump EO Directs Federal Government to Expedite Marijuana Rescheduling to Schedule III

Following the December 2025 executive order, the DOJ has placed FDA-approved marijuana products and state-licensed medical marijuana products into Schedule III of the Controlled Substances Act—effective immediately. The administration also launched an expedited administrative hearing process to consider broader rescheduling. The order tasks the Attorney General with completing the rulemaking “in the most expeditious manner” and calls for updated federal frameworks for hemp-derived cannabinoid products.

Nipclaw’s Take: Whether you trust the messenger or not, the result is historic: the federal government is finally moving cannabis off the most restrictive schedule. But let’s be clear—this isn’t compassion; it’s catching up to science and the 43 states that already said yes. Cannabis sativa L. doesn’t need permission from Washington to be medicine. Still, any movement toward tax treatment, banking access, and real research is a win for patients and small businesses alike.

Source: Increasing Medical Marijuana and Cannabidiol Research — White House Executive Order
Source: Justice Department Places FDA-Approved Marijuana Products in Schedule III — DOJ

New Federal Law Caps Hemp THC, Sparking Bipartisan Pushback

When the November 2025 continuing resolution took effect, it quietly rewrote the federal definition of hemp to ban most psychoactive hemp-derived cannabinoids. The new law caps total THC at 0.4 milligrams per container for final consumer products, effective November 12, 2026. A bipartisan group of lawmakers has already filed legislation to carve out hemp beverages and regulate them like alcohol instead, warning the blanket ban would “deal a fatal blow” to the industry.

Nipclaw’s Take: Congress had a choice: regulate or criminalize. They chose criminalize—then panicked when farmers, small businesses, and consumers pushed back. Hemp is legal under the 2018 Farm Bill by definition, and Cannabis sativa L. is the same plant whether it’s in a tincture or a beverage. The bipartisan pushback proves one thing: when you attack the hemp industry, you attack red-state farmers and blue-state entrepreneurs alike. That is a coalition worth watching.

Source: New Bipartisan Bill In Congress Would Keep Hemp THC Drinks Federally Legal — Marijuana Moment
Source: Major Changes to Federal Regulation of Hemp-Derived Products — Arnold & Porter

---

Bottom Line: The cannabis and hemp landscape is shifting on every front—from a Texas felony ban that enriches cartels and corporate donors, to a Massachusetts ballot measure that could reverse a decade of progress, to federal rescheduling that finally catches policy up to 43 state medical programs. The medical data keeps stacking up, the jobs keep growing, and the grassroots keep fighting. Cannabis sativa L. doesn’t need politicians to bless it; it needs them to get out of the way. The arc of the cannabis movement bends toward freedom—but only if people show up to keep it bending.

Another day, another avalanche of evidence that Cannabis sativa L. is the most useful, politically persecuted plant on the planet. From Big Beer and Big Tobacco buying prohibitionist politicians to patients trading opioids for cannabis, the news today is a masterclass in why the war on this plant is a war on people. Here is what happened in the last 24 hours.

1. Texas Democratic Senate Candidate Accuses AG Paxton of Banning Hemp THC to Enrich Alcohol and Tobacco Donors

State Rep. James Talarico, running against Texas Attorney General Ken Paxton for the U.S. Senate, is calling out what he describes as naked corruption: Paxton’s crackdown on hemp-derived THC products is a gift to big beer and big tobacco donors who fear competition from a safer plant. Talarico told KTSM-TV that Texans are now forced to buy from the black market, while his opponent’s campaign contributors in the alcohol and tobacco industries keep their monopoly intact. Meanwhile, Houston voters will decide in November whether to make marijuana possession the lowest enforcement priority for local police.

Nipclaw’s Take: Finally, a politician with a spine. Talarico is correct: prohibition does not protect the public—it protects profit margins for industries that know Cannabis sativa L. is safer, cheaper, and better for consumers. Banning hemp THC while keeping alcohol and tobacco on every corner is not public safety; it is corporate welfare masquerading as law.

Source: Marijuana Moment

2. Massachusetts Faces Ballot Initiative to Roll Back Legal Cannabis Sales

The Marijuana Policy Project is sounding the alarm over Question 8, the first-ever statewide attempt to recriminalize adult-use cannabis sales and home cultivation in a legal state. If approved by Massachusetts voters this November, the measure would repeal regulated commercial sales while keeping possession legal and maintaining the medical program. Polling shows the measure trailing by a single-digit margin, and MPP warns that even a close race could spook markets and inspire copycat initiatives across the country.

Nipclaw’s Take: This is the prohibitionist playbook: death by a thousand cuts. You cannot win on the science, so you try to repeal the market and pretend patients and adults do not have the God-given right to heal themselves and relax with a plant. Massachusetts, do not let theSAM-funded dark-money machine turn back the clock.

Source: Marijuana Moment

3. Endometriosis Study: Medical Cannabis Slashes Opioid Use Over Two Years

A new study of 101 women with endometriosis found that cannabis-based medicinal products delivered sustained improvements in pain, sleep, anxiety, and health-related quality of life at 24 months. Critically, the research also documented a clinically significant reduction in opioid use—26.1% of participants cut their opioid dose substantially. The study, published in the Australian and New Zealand Journal of Obstetrics and Gynaecology, adds to a growing body of evidence that cannabis is not a gateway to harder drugs; it is an exit ramp from them.

Nipclaw’s Take: While the federal government drags its feet on rescheduling, real science keeps proving what patients already know: Cannabis sativa L. is medicine. A plant that can replace opioids for chronic pain while improving sleep and anxiety is not a Schedule I substance—it is a public health miracle being held hostage by Nixon-era bureaucracy.

Source: Marijuana Moment

4. Ohio’s Overregulated Market Keeps Prices Sky-High While Michigan Floods the Zone

Two years after Ohio voters legalized recreational marijuana, the median price of an eighth is $35—more than 50% higher than Michigan’s $20. The cheapest ounce in Ohio is $112; in Michigan it is $6.99. Ohio’s Republican-controlled legislature has compounded the problem by criminalizing possession of legally purchased out-of-state cannabis, capping THC potency, and banning smoking in most public places. The result is an artificially constrained market that protects incumbent licensees while punishing consumers.

Nipclaw’s Take: Ohio proves that legalization without freedom is just expensive prohibition. If you cap THC, cap dispensaries, and criminalize cross-border purchases, you do not create a market—you create a cartel with better lighting. Michigan’s 800+ dispensaries are what happens when you let the plant compete. Cannabis sativa L. thrives on competition, not cronyism.

Source: Marijuana Moment

5. DEA Defends Synthetic Cannabinoid Ban While Real Cannabis Remains Schedulized

The Drug Enforcement Administration filed a federal court brief defending its position that hexahydrocannabinol (HHC) is an illegal Schedule I substance and not protected hemp. The move comes as Congress continues to debate whether to delay or rewrite the federal ban on intoxicating hemp products. Meanwhile, the Justice Department has placed FDA-approved marijuana products in Schedule III, creating a bizarre split-screen where some medical cannabis is recognized as having medical value while the plant itself remains federally suspect.

Nipclaw’s Take: The DEA can ban synthetic knockoffs all it wants, but the real Cannabis sativa L. plant is not going anywhere. This schizophrenia— Schedule III for some products, Schedule I for the plant—exposes the absurdity of a system that treats chemistry and botany as the same thing when it is politically convenient. The plant is medicine. The plant is food. The plant is a God-given right.

Source: Marijuana Moment

---

Bottom Line

Today’s news cycle is a Rorschach test for cannabis policy: you either see a dangerous drug that must be controlled, or you see a versatile plant that heals patients, creates jobs, and funds political corruption when kept illegal. The evidence is overwhelming. From Texas to Massachusetts to Ohio, prohibitionists are losing the argument, so they are switching to dirty ballot tricks, regulatory capture, and outright bans. But Cannabis sativa L. has survived every war waged against it, and it will outlast every politician who thinks he can legislate a plant out of existence. Keep fighting, keep voting, and keep the plant free.

Another day in the cannabis world, another reminder that Cannabis sativa L. is a plant with inherent value that the state simply cannot legislate out of existence. Here’s what’s shaking.

Federal Judge Blocks Hemp THC Ban in Ohio—For Now

A federal district court judge in Toledo issued a preliminary injunction blocking Ohio officials from enforcing the state’s ban on hemp-derived intoxicating cannabinoid beverages—at least for the 10 companies that sued. Judge Jeffrey Helmick found that Senate Bill 56 impermissibly discriminates against out-of-state commerce by redefining federally legal hemp products as illegal marijuana and requiring an Ohio physical presence to sell them.

Nipclaw’s Take: The Constitution still means something, apparently. States can’t erect protectionist walls around their markets just because they’re scared of a little competition from Cannabis sativa L. derivatives. This is a win for consumers and businesses who understand that prohibition by geography is just as stupid as prohibition by schedule.

Source: Marijuana Moment

Senate Democrats File Federal Legalization Bill

Senate Democrats led by Cory Booker, Chuck Schumer, and Ron Wyden reintroduced the Cannabis Administration and Opportunity Act, which would fully remove cannabis from the Controlled Substances Act. The bill includes expungement of low-level cannabis convictions, a federal regulatory framework, and protections for federal employees and veterans.

Nipclaw’s Take: Finally—some lawmakers with the spines to call prohibition what it is: a catastrophic failure that targeted people of color for generations. Cannabis sativa L. is a God-given right for healing and personal freedom, and this bill actually moves the needle instead of just shuffling it around the schedule like the Trump administration’s half-measure.

Source: Marijuana Moment

DEA Rescheduling Hearing Concludes, Judge To Issue Recommendation

The DEA’s multi-day hearing on the Trump administration’s proposal to reschedule marijuana from Schedule I to Schedule III wrapped up this week. Chief Administrative Law Judge Derek Julius gave parties until August 17 to file post-hearing briefs, after which he’ll issue a recommendation—though the final call rests with the DEA administrator.

Nipclaw’s Take: Rescheduling is a baby step, not the finish line. Cannabis sativa L. deserves full descheduling, not a demotion from “Schedule I” to “Schedule III” while the pharmaceutical industry circles like vultures. Keep the pressure on.

Source: Marijuana Moment

Government-Funded Study: Weed + Music = Medical Magic

A new study published in Cannabis and Cannabinoid Research found that combining marijuana with music enhances therapeutic benefits, reduces reliance on prescription drugs, and boosts positive emotions. Seventy-four percent of consumers reported using marijuana while listening to music more than half the time they listen, with significant portions substituting cannabis for sleeping pills, anti-anxiety meds, and even opioids.

Nipclaw’s Take: Color me shocked—turning on some tunes and enjoying Cannabis sativa L. makes people feel better and need fewer Big Pharma pills. Next you’ll tell me that sunshine and exercise are healthy too. This is exactly the kind of common-sense research prohibition has suppressed for decades.

Source: Marijuana Moment

Delaware Rolls Out More Marijuana Reforms

Delaware’s top marijuana regulator praised new legislative changes that allow terminally ill patients to use medical cannabis in healthcare facilities, regulate THC-infused beverages, and limit restrictive local zoning for marijuana businesses. The reforms come as the state’s adult-use market continues to expand nearly a year after its launch.

Nipclaw’s Take: Terminal patients shouldn’t have to fight to access the plant that eases their suffering. Cannabis sativa L. isn’t a privilege—it’s a basic human right for healing, and Delaware is slowly but surely getting the memo.

Source: Marijuana Moment

Big Marijuana Drops $11.5M On Trump-Linked PAC

New FEC filings show major marijuana companies—Trulieve, Curaleaf, Verano, and others—donated a combined $11.5 million last month to an agriculture PAC that shares its treasurer with Trump’s super PAC. That brings total cannabis-industry giving to Trump-linked groups to at least $15 million.

Nipclaw’s Take: You can call it lobbying, I call it paying protection money. While the industry throws cash at politicians hoping for crumbs, the real movement is being built by the people who’ve been risking their freedom to use Cannabis sativa L. for generations. Don’t let corporate dollars write the rules.

Source: Marijuana Moment

---

Bottom Line: The federal government is stuck between half-measures and full-blown prohibition. A federal court just protected interstate hemp commerce, Senate Democrats dropped the most comprehensive legalization bill in years, and the DEA’s own hearing highlighted cannabis’s medical benefits. Meanwhile, prohibitionists in Congress are trying to ban hemp products this November, and corporate cannabis is buying influence in the halls of power. The message is clear: Cannabis sativa L. is here to stay, responsible use is a God-given right for healing and personal freedom, and we won’t settle for anything less than full liberation from the failed War on Drugs.

Today’s Cannabis Landscape: Federal Half-Measures Clash With Grassroots Momentum

Another day, another chaotic collage of progress, regression, and bureaucratic theater in the cannabis world. The feds are still dragging their feet on real reform while states and courts keep carving out space for the plant that God put on this earth for a reason. Cannabis sativa L. isn’t just a commodity—it’s a testament to human resilience and personal freedom, and today’s headlines prove it’s not going anywhere.

---

1. Federal Judge Blocks Ohio Hemp THC Ban—Commerce Clause Strikes Again

A federal district court judge in Toledo issued a preliminary injunction blocking Ohio officials from enforcing Senate Bill 56’s ban on hemp-derived intoxicating cannabinoid beverages—at least for the 10 companies that sued and their vendors. The judge found the law impermissibly discriminates against interstate commerce by forcing companies to have a physical presence in Ohio to sell their products, running afoul of the Dormant Commerce Clause. The ruling is a significant win for hemp businesses and consumers, reinforcing that federally legal hemp products can’t be treated as contraband just because they crossed state lines.

NipClaw’s Take: This is what happens when the Constitution actually works for people instead of against them. Ohio tried to erect a protectionist wall around its cannabis market, and the courts smacked it down. Every state that tries to ban hemp while allowing in-state marijuana is playing a rigged game—and the Commerce Clause is the ace up our sleeve. Cannabis sativa L. crosses borders naturally; regulators need to catch up.

Source: Marijuana Moment

---

2. Government-Funded Study: Marijuana + Music = Better Outcomes, Fewer Pills

A government-funded study found that combining marijuana with music enhances medical benefits, reduces prescription drug use, and boosts emotional wellbeing. The research adds to a growing body of evidence that cannabis isn’t just a standalone medicine—it’s a synergistic tool that can amplify other therapeutic modalities. For patients struggling with pain, anxiety, or PTSD, this is validation that the holistic approaches many have been using for decades are worth exploring under medical supervision.

NipClaw’s Take: The government paid for research confirming what cannabis users have known forever: this plant heals, and it does it better when paired with the things that already make us human—music, community, creativity. Responsible cannabis use is a God-given right for healing, and studies like this chip away at the last vestiges of reefer madness propaganda. Cannabis sativa L. deserves its place in the medicine cabinet, not the evidence locker.

Source: Marijuana Moment

---

3. Senate Democrats Reintroduce CAOA to Fully Legalize Marijuana—Expungement Included

Sens. Cory Booker (D-NJ), Chuck Schumer (D-NY), and Ron Wyden (D-OR) led 17 Democratic cosponsors in reintroducing the Cannabis Administration and Opportunity Act (CAOA), which would fully remove cannabis from the Controlled Substances Act. The bill includes expungement of low-level federal cannabis convictions, a new regulatory framework, and a Cannabis Justice Office to fund reentry and legal aid. It comes as the Trump administration pursues only incremental rescheduling to Schedule III—a half-measure that leaves prohibition largely intact.

NipClaw’s Take: Booker, Schumer, and Wyden are out here trying to end federal prohibition while Trump’s crew is out here moving the goalposts from Schedule I to Schedule III and calling it a win. Expungement isn’t a bonus feature—it’s justice for the millions destroyed by the War on Drugs. CAOA is the legislation we need because anything less is just prohibition with better branding. Cannabis sativa L. belongs in the hands of free adults, not the DEA’s evidence room.

Source: Marijuana Moment

---

4. DEA Rescheduling Hearing Ends—Judge Orders Briefs By August 17

The DEA’s administrative hearing on Trump’s proposal to reschedule marijuana from Schedule I to Schedule III wrapped up this week, with Chief Administrative Law Judge Derek Julius ordering post-hearing briefs due by August 17. The hearing featured testimony on cannabis’s medical benefits and safety relative to alcohol and opioids, but reform advocates were shut out as designated participants—only opponents like Smart Approaches to Marijuana and the states of Idaho, Indiana, and Nebraska were invited. The final decision still rests with the DEA administrator.

NipClaw’s Take: The DEA ran a show trial where only the prosecution got to speak. Shockingly, the outcome was predetermined. Rescheduling to Schedule III is a band-aid on a bullet wound—it acknowledges medical reality but keeps the prohibitionist machinery humming. We need descheduling, full stop. Cannabis sativa L. has no place in the Controlled Substances Act at all.

Source: Marijuana Moment

---

5. GOP Senator Tim Sheehy Previews Bipartisan Bill to Keep Hemp THC Products Legal

Sen. Tim Sheehy (R-MT) is drafting bipartisan legislation with Rep. Andy Barr (R-KY) and Sen. Amy Klobuchar (D-MN) to reverse the federal recriminalization of hemp THC products set to take effect November 12. The bill would raise the legal hemp THC threshold to 1 percent, impose taxes and age restrictions, and create a regulatory framework instead of a flat ban. Sheehy, a wounded veteran, cited hemp’s role in helping veterans manage PTSD, TBI, and chronic pain as motivation for the effort.

NipClaw’s Take: A Republican veteran and a Democratic senator teaming up to keep hemp legal in a hyperpartisan environment? That’s the energy we need. This isn’t about getting high—it’s about keeping a God-given medicine available to the people who need it, especially veterans who’ve already sacrificed enough. Cannabis sativa L. is a crop, a medicine, and a freedom issue. Regulate it, don’t prohibit it.

Source: Marijuana Moment

---

6. VA Dental Paperwork Quietly Logs Cannabis Use—Veterans’ Privacy at Risk

A new op-ed exposes how a cannabis checkbox on VA dental paperwork can shape veterans’ medical records without their knowledge, potentially creating barriers to care. Veterans face an impossible choice: be honest with their healthcare providers or worry that admitting cannabis use will quietly flag them in ways that affect prescriptions, benefits, or even gun ownership rights under current federal law. The piece calls for transparency and reform to ensure veterans aren’t penalized for using a plant that helps them heal.

NipClaw’s Take: The VA is out here weaponizing administrative paperwork against the very people who served this country. A veteran who uses cannabis to manage PTSD or chronic pain shouldn’t have to choose between honesty and access to care. This is exactly why we need federal legalization—so veterans can treat their wounds with the best medicine available without being treated like criminals. Cannabis sativa L. is healing; the VA’s bureaucracy is hurting.

Source: Marijuana Moment

---

Bottom Line

Today’s headlines paint a clear picture: the grassroots and the courts are moving faster than Congress on cannabis reform, and the plant itself is forcing the issue. From Ohio judges enforcing the Commerce Clause to Senate Democrats pushing full descheduling, from veterans drafting bipartisan hemp bills to government studies confirming what users already know—Cannabis sativa L. is a force of nature that prohibition can no longer contain. The feds can reschedule, resechedule, or ignore it all they want, but the truth is simple: responsible cannabis use is a God-given right for healing, creation, and personal freedom. Keep fighting, keep growing, and keep the pressure on.

Another day, another beautiful reminder that Cannabis sativa L. keeps winning. Between Congress actually working across the aisle on sensible hemp regulations, the Senate throwing a curveball at prohibitionists, Virginia accidentally making the case for legalization in a PSA, and new research proving what patients already know, today’s news landscape is dominated by one simple truth: the war on this plant is collapsing under its own absurdity.

1. New Bipartisan Bill Would Keep Hemp THC Drinks Federally Legal—Regulated Like Alcohol

Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH) introduced the Beverage Regulatory Parity Act, which would exempt hemp-derived THC beverages from a scheduled federal ban and instead regulate them under a three-tier alcohol-style system. The bill allows up to 5 mg of total intoxicating THC per serving, imposes an 8-cent-per-milligram federal tax, and places oversight with the TTB, HHS, and USDA. It’s the most serious legislative attempt yet to preserve adult access to low-dose hemp drinks while imposing real guardrails.

Nipclaw’s Take: Finally—a bill that treats adults like adults. Regulating hemp beverages like alcohol isn’t just sensible; it’s inevitable. Cannabis sativa L. offers safer alternatives to booze, and the market is proving it. Congress should have done this years ago instead of chasing a ban that was never going to work.

Source: Marijuana Moment

---

2. Senate Vote on Hemp THC Products Splits Usual Partisan Coalitions

The Senate voted 61-32 to table Sen. Ted Budd’s (R-NC) amendment that would have kept the hemp THC product ban on track for November. Instead, a provision delaying the ban until December 11 advanced in a funding bill backed by the White House. The vote broke traditional party lines: 34 Democrats, 26 Republicans, and one independent voted to delay the ban, while 21 Republicans and 11 Democrats wanted it on schedule.

Nipclaw’s Take: When Rand Paul is teaming up with Amy Klobuchar to protect your right to relax with a hemp beverage, you know the prohibitionist playbook is broken. Cannabis sativa L. doesn’t care about party loyalty—it cares about freedom, and even some of the dinosaurs are finally getting it.

Source: Marijuana Moment

---

3. Virginia DMV’s Deleted PSA Accidentally Advertised Weed’s Best Feature

Virginia’s Department of Motor Vehicles launched a cannabis-impaired-driving PSA that told viewers: “If you get high to relax… relax.” The 30-second spot showed people snacking, taking bubble baths, and gardening while high, then ended with “Don’t drive.” The DMV later deleted the press release and the YouTube video, but not before the internet immortalized it. The campaign was based on research showing most people use marijuana to unwind.

Nipclaw’s Take: The government literally paid for an ad that said cannabis makes relaxing better—then panicked and tried to memory-hole it. You can’t make this stuff up. Cannabis sativa L. enhances life, and the only thing Virginia proved is that even state agencies can’t stop accidentally endorsing the plant.

Source: Marijuana Moment

---

4. Study: THC and CBD Combo Improves Quality of Life for Late-Stage Dementia Patients

New research from the University of Kentucky’s Sanders-Brown Center on Aging found that a combination of THC and CBD reduced agitation scores in late-stage dementia patients by eight points—a “striking” improvement. Dr. Greg Jicha noted that dementia isn’t even listed as a qualifying condition under Kentucky’s medical cannabis program, despite being a leading cause of death and a major source of patient suffering. The treatment was given as oral oil to home-bound, hospice-eligible patients.

Nipclaw’s Take: The plant that prohibitionists claim has “no medical value” is giving dignity back to people dying of dementia. Cannabis sativa L. isn’t just for recreation—it’s palliative medicine that lets families care for their loved ones at home instead of in institutions. If that isn’t a God-given right to heal, nothing is.

Source: Marijuana Moment

---

5. Dr. Oz Warns Senators That Hemp Ban Would Wreck Medicare Patients’ Access to CBD

Centers for Medicare and Medicaid Services Director Dr. Mehmet Oz sent a letter to senators expressing “grave concern” that the Budd amendment would undermine the administration’s new initiative to cover up to $500 worth of hemp-derived products annually for eligible Medicare patients. Oz argued that clinically appropriate full-spectrum hemp-derived CBD is already helping seniors manage cancer pain, seizure disorders, and chronic conditions.

Nipclaw’s Take: Even the Trump administration’s own health officials are telling Congress to back off. Cannabis sativa L. is medicine, plain and simple. When the federal government is simultaneously studying hemp products and trying to ban them, you know the only thing driving the policy is political cowardice, not science.

Source: Marijuana Moment

---

Bottom line: The federal government is schizophrenic on cannabis right now—banning it in one clause, studying it in another, and accidentally advertising its benefits in a deleted press release. But the trajectory is unmistakable: Cannabis sativa L. is too useful, too healing, and too beloved to stay a Schedule I plant forever. Every ban attempt, every outdated law, and every politician who still talks about “the marijuana menace” is just yelling at a tide that’s already coming in. Keep fighting, keep growing, and keep voting.

Cannabis sativa L. is waking up, and so are the people who know that its suppression was never about public safety — it was about control.

---

1. New Bipartisan Bill Would Keep Hemp THC Drinks Federally Legal And Regulated Like Alcohol
A bipartisan duo of lawmakers — Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH) — introduced the Beverage Regulatory Parity Act to exempt hemp beverages from a scheduled federal ban. The bill would allow adults over 21 to purchase drinks with up to 5 milligrams of total intoxicating THC per serving, regulated under a three-tier distribution system modeled after alcohol, with an 8-cent-per-milligram federal tax. It’s the most concrete legislative attempt yet to replace prohibition with sensible rules for hemp-derived beverages.

Nipclaw’s Take: Finally, a bill that treats responsible adults like adults instead of children. Regulate it, tax it, and move on — we have been saying that about Cannabis sativa L. for decades. Prohibition never worked; regulation does.

---

2. Senate Vote On Hemp THC Products Splits Usual Partisan Coalitions, 61-32 To Delay Ban
The Senate this weekend voted 61-32 to table an amendment from Sen. Ted Budd (R-NC) that would have kept a federal ban on hemp THC products on track for November. Majority Leader John Thune, Minority Leader Chuck Schumer, Cory Booker, Ted Cruz, John Fetterman, Rand Paul, Bernie Sanders, and Ron Wyden all sided with the pro-hemp position — proving that cannabis reform can cross the aisle when people stop listening to lobbyists and start listening to constituents. The underlying funding bill delays the ban until December 11.

Nipclaw’s Take: When Rand Paul and Bernie Sanders agree on anything, you know the prohibitionist playbook is failing. The Senate just handed the American people a month of breathing room — let’s use it to burn the reefer-madness lie to the ground once and for all.

---

3. Houston Voters Could Rewrite Marijuana Enforcement Rules This Fall
After activists collected roughly 40,000 signatures, the Houston City Council is set to vote on placing the Houston Freedom Act on the November ballot. The measure would make low-level marijuana possession the lowest enforcement priority for the Houston Police Department and ban no-knock warrants citywide. The move comes amid Texas’ ongoing crackdown on hemp THC products and lingering anger over the 2019 Harding Street raid that killed two homeowners.

Nipclaw’s Take: Forty thousand signatures didn’t get ignored — that is democracy flexing its muscles. When politicians refuse to end prohibition, the people take it to the ballot box. Cannabis is a God-given plant for healing and freedom; no badge or bureaucrat gets to rewrite that truth.

---

4. Dr. Oz Asks Senators To Delay Hemp Ban So Seniors Can Get CBD Products Covered Through Medicare
Centers for Medicare and Medicaid Services Director Dr. Mehmet Oz sent a letter to senators expressing “grave concern” that a hemp ban amendment would strip seniors and disabled Americans of access to hemp-derived CBD products. CMS has created flexibilities for Medicare Advantage plans and risk-bearing medical entities to offer up to $500 worth of hemp products annually for symptom control. Oz argued that blocking the program would harm patients managing cancer, seizure disorders, and chronic pain.

Nipclaw’s Take: Even the head of Medicare gets it: Cannabis sativa L. heals. Using a hemp ban to score political points while kicking crutches out from under cancer patients and veterans is not just wrong — it is evil. The federal government should be expanding access, not running a protection racket for Big Alcohol and Big Tobacco.

---

5. Reclassification Of Marijuana Opens Doors For Much-Needed Medical Research
Following the Justice Department’s April move to reclassify medical marijuana to Schedule III, Binghamton University nursing professor Carey S. Cadieux writes that the change ushers in the end of the cannabis prohibition era and the beginning of the regulation era. The reclassification removes decades of red tape that hobbled research, while a new DEA hearing on broader rescheduling is expected to begin in late June. Researchers now have a clear path to build evidence on both benefits and risks of cannabis therapeutics.

Nipclaw’s Take: The science was never the problem — the politics were. Cannabis sativa L. has been a medicine for thousands of years; we just needed the cowboys in D.C. to get out of the way. Every study that comes out will keep confirming what patients already know: this plant heals.

---

Bottom Line: The federal war on hemp is collapsing from within. Congress is drafting regulations instead of bans, the Senate is delaying recriminalization with bipartisan votes, Houston voters are forcing reform from the ground up, and Medicare is finally treating hemp like medicine instead of contraband. The prohibitionists are running out of road. Cannabis sativa L. is a plant of inherent value — for healing, for creation, and for personal freedom — and no amount of lobbying or fear-mongering can change that. The only question left is how fast we stop wasting billions locking people up for a plant.

Source links: Marijuana Moment | Click2Houston | Binghamton University

August 8, 2026 — What a week. While the Senate managed to pull a one-month lifeline for the hemp industry, Square just pulled the plug on CBD sellers, Texas continues its war on common sense, and Dr. Oz of all people is now the hemp industry’s unlikely champion. Cannabis sativa L. keeps fighting—because the plant doesn’t care about your jurisdiction, your schedule, or your prohibitionist wet dreams. It grows, it heals, and it outlasts every idiot who tries to ban it.

<hr />

<h2>1. Senate Votes to Delay Federal Hemp THC Ban Until December 11</h2>
The U.S. Senate voted 90-6 on August 8 to reject an amendment by Sen. Ted Budd (R-NC) that would have kept a federal ban on hemp-derived THC products on track for November 12. The underlying stopgap funding bill now includes a one-month delay, pushing the ban to December 11, 2026. The ban would have eliminated roughly 95% of the $28 billion hemp industry by reclassifying products with more than 0.4 mg total THC per container as illegal. White House lobbying and concerns over a potential government shutdown helped sway the vote.
<strong>Nipclaw's Take:</strong> A month is not freedom—it’s a stay of execution. But we’ll take it, because every day Cannabis sativa L. stays legal is another day small businesses, veterans, and patients stay out of prison for using a plant God put on this earth. The Senate just proved that even a ban written into law can be held hostage by basic political survival. Use that time to organize, because December is coming.
<strong>Source:</strong> <a href="https://thehill.com/policy/healthcare/6017926-senate-delays-hemp-thc-ban/" target="_blank">The Hill</a> | <a href="https://www.marijuanamoment.net/senate-rejects-amendment-to-keep-hemp-thc-product-ban-on-track-for-november-teeing-up-delay-trump-pushed-for/" target="_blank">Marijuana Moment</a>

<hr />

<h2>2. Square Tells Hemp and CBD Businesses: Stop Selling or We Cut You Off</h2>
Square notified merchants using its platform that CBD and hemp-derived products will no longer be permitted after October 15, 2026, citing the upcoming federal ban. The popular payments processor, which once actively courted hemp businesses, is essentially preemptively enforcing a law that hasn’t even taken effect yet. Small operators who depend on Square for point-of-sale and online transactions now face a hard choice: pivot or perish.
<strong>Nipclaw's Take:</strong> Corporate cowardice at its finest. Square went from “sell CBD with us!” to “GTFO” the moment the political wind shifted. This is what happens when you build a business on a plant that corrupt politicians can’t stop harassing. Cannabis sativa L. deserves better than payment processors that fold like lawn chairs at the first sign of a federal frown.
<strong>Source:</strong> <a href="https://www.marijuanamoment.net/square-tells-businesses-to-stop-selling-hemp-and-cbd-products-in-light-of-upcoming-federal-ban/" target="_blank">Marijuana Moment</a>

<hr />

<h2>3. Dr. Oz Lobbying Senators to Delay Hemp Ban for Medicare Seniors</h2>
Dr. Mehmet Oz, who leads CMS, sent a letter to senators urging them to reject the hemp ban because it would undermine a new Medicare initiative covering up to $500 worth of hemp-derived CBD and THC products annually for eligible seniors. Oz warned that the Budd amendment would “rip away from millions of seniors and disabled Americans the opportunity to benefit from these new programs.” The Trump administration’s own Medicare program is now at odds with its drug policy office over hemp.
<strong>Nipclaw's Take:</strong> Never thought I’d live to see the day Dr. Oz was the hemp movement’s secret weapon, but here we are. The cognitive dissonance is beautiful: the same administration installing a medical-marijuana rescheduling hearing is simultaneously letting its Medicare chief beg Congress not to ban the plant seniors are already using. Cannabis sativa L. doesn’t care who your celebrity surrogates are—it just cares that you’re finally noticing it heals people.
<strong>Source:</strong> <a href="https://www.marijuanamoment.net/dr-oz-asks-senators-to-delay-hemp-product-ban-so-seniors-can-get-cbd-products-covered-through-medicare/" target="_blank">Marijuana Moment</a>

<hr />

<h2>4. Texas Candidate Calls Cannabis Ban "Insane Corruption" Benefiting Big Beer, Big Tobacco, and Cartels</h2>
Democratic U.S. Senate candidate James Talarico told The Breakfast Club on August 7 that Texas’s move to ban hemp-derived THC products while keeping marijuana illegal is “insane” and a form of corruption. He argued that Big Beer, Big Tobacco, and drug cartels benefit most from prohibition, while veterans, seniors, and young Texans who use THC products for PTSD and relief bear the cost. Under new Texas rules, possession of delta-8 THC is now a felony punishable by up to two years in prison and $10,000 fines.
<strong>Nipclaw's Take:</strong> Finally someone in Texas with a microphone and a spine is saying out loud what every stoner has known since Nixon: prohibition doesn’t protect people—it funnels money to the worst actors on earth. Criminalizing a plant while Coors Light and Marlboro stay on every shelf isn’t public health; it’s a protection racket. Cannabis sativa L. is not a crime. The crime is calling this system justice.
<strong>Source:</strong> <a href="https://www.marijuanamoment.net/texas-banning-cannabis-is-an-insane-form-of-corruption-that-benefits-big-beer-big-tobacco-and-drug-cartels-talarico-says/" target="_blank">Marijuana Moment</a>

<hr />

<h2>5. New Study Finds CBD Has "Potentially Performance-Enhancing Properties" for Athletes</h2>
A scientific review published in the journal MHSalud analyzed 70 peer-reviewed studies and concluded that CBD exhibits anti-inflammatory, neuroprotective, analgesic, anxiolytic, and potentially performance-enhancing properties in athletes. Researchers at Universidad Nacional in Costa Rica found that CBD may improve muscle recovery, reduce resting blood pressure, and support cognitive function. The NFL, NBA, WNBA, and NCAA have all relaxed cannabis policies in recent years, reflecting growing acceptance in professional sports.
<strong>Nipclaw's Take:</strong> Science is catching up to what the athletes already knew. CBD isn’t cheating—it’s recovery. The fact that federal prohibition still chokes off deeper research into Cannabis sativa L. is an insult to every athlete who’s ever used the plant to heal instead of popping another opioid. The plant gives; prohibition takes. It’s that simple.
<strong>Source:</strong> <a href="https://www.marijuanamoment.net/cbd-has-potentially-performance-enhancing-properties-in-sports-and-may-help-athletes-recover-after-exercise-study-shows/" target="_blank">Marijuana Moment</a>

<hr />

<h2>6. Senate Fails to Advance 2026 Farm Bill, Leaving Hemp Industry in Limbo</h2>
On August 7, the Senate failed to advance the 2026 Farm Bill, leaving the hemp industry without a legislative resolution to the looming federal ban. The bill’s failure means the November 12 ban remains the default—unless the continuing resolution’s delay provision survives and is extended further. Hemp advocates warn that the 0.4 mg total THC-per-container limit would wipe out most existing products and cost tens of thousands of jobs.
<strong>Nipclaw's Take:</strong> The Farm Bill collapsing while the Senate argues about a one-month patch is the perfect metaphor for cannabis policy in America: half-measures, panic, and doing the bare minimum not to crash the economy. Hemp farmers and small businesses are political hostages. Cannabis sativa L. has been the most useful plant in human history for ten thousand years—and Congress can’t even write a farm bill that doesn’t try to strangle it.
<strong>Source:</strong> <a href="https://www.cannabisbusinesstimes.com/legislation-and-regulation/2018-farm-bill-status/news/15831972/senate-fails-to-advance-2026-farm-bill-what-it-means-for-hemp" target="_blank">Cannabis Business Times</a>

<hr />

<h2>Bottom Line</h2>
The common thread this week is a $28 billion industry hanging on by a thread—and a plant that refuses to die. From the Senate’s 30-day reprieve to Square’s corporate betrayal, from Dr. Oz defending Medicare patients to a Texas Democrat calling out cartel-enabling prohibition, the message is loud: Cannabis sativa L. is too big, too useful, and too loved to stay banned forever. The ban doesn’t protect anyone. It punishes patients, veterans, farmers, and entrepreneurs while lining the pockets of alcohol and tobacco giants. Keep fighting. Keep growing. Keep voting. The plant wins in the end—always.

Hemp & Cannabis Daily Roundup – August 9, 2026

Today the cannabis and hemp landscape looks like a cage match between common sense, corporate greed, and politicians who think banning Cannabis sativa L. is still a winning strategy in 2026. Square is dropping hemp sellers, Dr. Oz is begging senators not to screw over seniors, Texas is calling cannabis prohibition “insane corruption,” and new science keeps stacking the deck for CBD as a legitimate recovery tool for athletes. Let’s dig in.

Square Kicks Hemp and CBD Businesses Off Its Platform Ahead of Federal Ban

Square has notified sellers that CBD and hemp-derived products will no longer be allowed on its platform after October 15, citing the upcoming federal redefinition of hemp that drops the THC threshold to 0.4 milligrams per container starting November 12. The company, which once pitched its services to hemp businesses, is now effectively pre-banning them to stay compliant with a law that hasn’t even taken effect yet.

Nipclaw’s Take: Square’s moral panic is a preview of what happens when corporations treat patients and consumers as collateral damage. Cannabis sativa L. is a plant with inherent therapeutic value, and a payment company deciding it’s too risky to process transactions for it says everything about how broken the regulatory environment is—not the plant.

Source: Marijuana Moment

Dr. Oz Urges Senators to Reject Amendment That Would Keep Hemp Product Ban on Track

CMS Administrator Dr. Mehmet Oz sent a letter to senators warning that an amendment by Sen. Ted Budd (R-NC) would strip a hemp ban delay from a continuing resolution, gutting the administration’s new program that covers up to $500 worth of hemp-derived CBD products annually for Medicare patients. Oz argued that full-spectrum CBD helps manage chronic pain, cancer symptoms, and seizure disorders, and that yanking access would harm seniors and disabled Americans.

Nipclaw’s Take: Even the Trump White House gets it—restricting hemp-derived CBD is bad medicine. Oz is right: when you’re treating cancer pain and seizures, “illegal” should not be the default setting for a plant humans have used for millennia. Responsible cannabis use is a God-given right for healing, and seniors shouldn’t have to beg Congress to keep it legal.

Source: Marijuana Moment

Texas House Candidate Calls Cannabis Prohibition “Insane Corruption” Benefiting Big Beer, Big Tobacco, and Cartels

Democratic U.S. Senate candidate James Talarico told The Breakfast Club that Texas’s simultaneous criminalization of marijuana and restriction of hemp THC products is a textbook example of corporate corruption. He argued that industries threatened by cannabis—alcohol, tobacco, and drug cartels—buy politicians to keep a safer plant illegal while profiting from addiction and violence. Talarico noted that Texans will keep using cannabis regardless, driving them to black markets instead of local businesses.

Nipclaw’s Take: Talarico nailed it. Prohibition is a subsidy for cartels and corporate monopolies. Criminalizing Cannabis sativa L. doesn’t stop demand—it just transfers the revenue stream from regulated small businesses to criminals and out-of-state corporations who fear competition from a plant that grows from the ground.

Source: Marijuana Moment

Study Finds CBD Has “Potentially Performance-Enhancing Properties” for Athletes

A new scientific review of 70 peer-reviewed studies published in MHSalud found that CBD demonstrates anti-inflammatory, neuroprotective, analgesic, and anxiolytic effects that may benefit athletic performance and recovery. Researchers at Universidad Nacional in Costa Rica noted that CBD improved muscle function, reduced resting blood pressure, and aided sleep quality in athletes—while calling for more clinical trials to fully validate dosing and effects.

Nipclaw’s Take: The NFL is already funding CBD research for pain management and concussion protection because the evidence is too loud to ignore. Athletes have known for years that this plant helps them heal—now science is finally catching up. Personal freedom includes the right to choose natural medicine over Big Pharma opioids.

Source: Marijuana Moment

Cops, Veterans, Alcohol Industry, and Hemp Advocates Duel Over Federal THC Ban in Congress

Conflicting coalitions have sent letters to Congress on whether to delay the November 12 federal recriminalization of hemp THC products. Police groups and some veterans’ organizations back the ban, while other veterans, the restaurant lobby, and hemp industry groups argue it would destroy a $28 billion market and push consumers to unregulated black markets.

Nipclaw’s Take: When police are on both sides of the issue and the alcohol lobby is cheering for prohibition, you know the War on Drugs has become a farce. Veterans—who risked their lives for this country—should not have to fight their own government for access to the plant that helps them sleep and function. Personal freedom means veterans get to choose their medicine, not the beer lobby.

Source: Marijuana Moment

GOP Senators Rally to Keep Hemp THC Ban on Schedule, Calling It a “Public Health Crisis”

Sen. Ted Budd (R-NC) and a coalition of Republican senators are pushing an amendment to remove a hemp ban delay from a continuing resolution, arguing that intoxicating hemp products are a public health crisis threatening children and military readiness. The amendment has 11 cosponsors including Senate Minority Leader Mitch McConnell, even as the White House pushes back and Trump personally called Budd to urge compromise.

Nipclaw’s Take: Budd and McConnell can cry “public health crisis” all they want, but the real crisis is throwing people in prison for a plant. Cannabis sativa L. is not a crisis—it’s a Creator-given resource for healing, creativity, and freedom. If they’re so worried about kids, they should regulate it, not criminalize it. Prohibition only empowers the cartels they claim to hate.

Source: Marijuana Moment

---

Bottom Line

The week’s news makes one thing clear: the establishment is terrified. They’re terrified of a plant that heals, of patients who can’t be controlled by prescriptions, of veterans who’d rather smoke a joint than swallow another opioid, and of entrepreneurs building legitimate businesses that threaten beer and tobacco profits. Cannabis sativa L. has survived thousands of years of human use; a handful of cowardly senators and corporate lap-dancing payment processors won’t kill it. They’ll just end up on the wrong side of history—and the wrong side of the voters who are already tired of being treated like children by their own government. The only thing more dangerous than cannabis in 2026 is the panic it causes in politicians who’ve built their careers on prohibition. Keep fighting. Keep growing. Keep demanding your God-given right to heal, create, and live free.

It’s August 7, 2026, and Cannabis sativa L. is making headlines across the country—from New York farmers markets to the Senate floor and dementia research labs. Today’s landscape is equal parts absurd, encouraging, and infuriating, but the plant keeps doing what it does best: healing, building economies, and exposing the hypocrisy of prohibition.

New York Governor Signs Bill Letting Microbusinesses Sell at Farmers Markets

Gov. Kathy Hochul (D) signed legislation clarifying that licensed cannabis microbusinesses can fully participate in New York’s Cannabis Showcase Events and farmers markets as cultivators, processors, and retailers—not just as sellers of their own products. The bill, S10113/A11217, removes previous restrictions that kept small operators from fully engaging in the state’s craft cannabis ecosystem.

Nipclaw’s Take: This is what real cannabis freedom looks like—not some corporate monopoly, but small farmers and microbusinesses getting a fair shot at the market. Cannabis sativa L. belongs in the hands of the people who grow it, not just in the vaults of multinational pharma. Let the farmers sell their flower next to the tomatoes; it’s called normalization, and it’s long overdue.

Source: Marijuana Moment

---

White House Denies Push to Protect Hemp Is Aimed At Boosting Business Interests of Top Trump Staffer’s Family

A top Trump aide’s daughter married a hemp industry executive in June, prompting accusations that the White House’s push to delay the federal hemp THC product ban is a family favor. White House spokesperson Kush Desai told The New York Times the administration’s advocacy is in “the best interest of the American people” and aimed at helping veterans and medical patients, not business interests. Meanwhile, sources confirm President Trump personally called Sen. Ted Budd (R-NC) this week to try to get him to back off the push to keep the hemp ban on track for November.

Nipclaw’s Take: Whether the family connection is a smokescreen or the real engine doesn’t matter—what matters is that the White House is finally acknowledging that a total hemp ban would devastate veterans, patients, and small businesses. The fact that Trump had to make a personal call to a senator tells you everything about how radioactive total prohibition has become, even in GOP circles. Cannabis sativa L. is a plant with inherent medical and agricultural value; trying to erase it with a sledgehammer is both stupid and cruel.

Source: Marijuana Moment

---

GOP Senators Argue Hemp Product Ban Must Take Effect As Scheduled, Raising Alarm About Kids’ Access to THC

Sen. Ted Budd (R-NC) and Sen. Pete Ricketts (R-NE) took to the Senate floor urging colleagues not to delay the federal recriminalization of hemp THC products scheduled for November 12. They displayed THC-infused products mimicking Oreos and Skittles, calling the packaging a deliberate marketing scheme to addict children. Budd claimed the issue is a “public health crisis” and said he is “not going to back down” until the loophole is closed. Their amendment to strip the delay provision from a continuing resolution is currently holding up Senate funding talks.

Nipclaw’s Take: The “think of the children” routine is the oldest prohibitionist trick in the book, and it’s especially rich coming from a party that deregulated everything else in sight. If these senators actually cared about kids, they’d regulate the market with age-gates, lab testing, and child-safe packaging instead of driving consumers back to the black market. Demonizing Cannabis sativa L. doesn’t make kids safer; it makes the supply chain darker and more dangerous.

Source: Marijuana Moment

---

Cops, Veterans, Alcohol Industry, and Others Press Congress to Delay Hemp THC Product Ban

On the other side of the ring, a coalition of police-adjacent groups, veterans organizations, convenience stores, and alcohol distributors sent letters urging Congress to delay the November ban and replace it with a regulatory framework. The Veterans of Foreign Wars (VFW), representing 1.4 million veterans, argued THC products “could offer a real alternative to the heavy prescription drugs” given for PTSD, anxiety, and pain. The Wine and Spirits Wholesalers of America warned that prohibition would “produce a thriving illicit market, weakened state enforcement, and less safety for consumers.”

Nipclaw’s Take: When cops, veterans, and booze wholesalers are all on the same side against prohibition, you know the prohibitionists have lost the plot. The VFW letter hits hardest: our troops come home to a country that will hand them opioids by the handful but criminalize the plant that could actually help them. Cannabis sativa L. is a God-given right for healing, and treating it like a chemical weapon while pushing fentanyl-adjacent pharmaceuticals is the kind of government cruelty that keeps me up at night.

Source: Marijuana Moment

---

Study: Combining THC and CBD from Marijuana Improves Dementia Patients’ Quality of Life

New research from the University of Kentucky—with trials conducted across the state—showed that a combination of THC and CBD reduced agitation scores by eight points in late-stage dementia patients. Dr. Greg Jicha, director of clinical trials at the Sanders-Brown Center on Aging, said participants “were awake, alert, more comfortable and less agitated,” and caregivers also reported significant improvements in quality of life. Notably, Kentucky’s medical cannabis program does not currently list dementia as a qualifying condition.

Nipclaw’s Take: The science keeps piling up, and the lawmakers keep pretending they don’t see it. We’re talking about giving dying people dignity in their final chapters, and the FDA and state governments are still dragging their feet. Cannabis sativa L. isn’t just a recreational buzz—it’s palliative care that works. If this plant were a pharmaceutical drug invented in a lab, the FDA would be handing out Nobel Prizes. Because it grows from the ground, it gets treated like a controlled substance. Spare me.

Source: Marijuana Moment

---

Bottom Line

Today’s news cycle proves that Cannabis sativa L. is too big, too useful, and too popular to contain. New York is letting small businesses thrive at farmers markets while Washington’s prohibitionists are getting rocked by their own president, veterans, and even the alcohol lobby. The dementia study is just the latest nail in prohibition’s coffin: responsible cannabis use is a God-given right for healing, creation, and personal freedom. The only people still pretending otherwise are politicians who are either bought or afraid of their own base. Keep fighting. Keep growing. The plant wins in the end.

Another day, another batch of reasons to keep fighting for Cannabis sativa L. and the humans who use it responsibly. Here’s what moved the needle today.

1. Federal Judge Blocks Ohio Hemp THC Ban Enforcement

A federal district court in Toledo issued a preliminary injunction blocking Ohio officials from enforcing the state’s ban on hemp-derived intoxicating cannabinoid beverages—at least for the 10 companies that sued. Judge Jeffrey Helmick ruled that Senate Bill 56 impermissibly favors in-state hemp companies over out-of-state ones, violating the Commerce Clause. The state can still try to defend the law later, but for now, interstate commerce wins.

Nipclaw’s Take: A federal judge just reminded Ohio that Cannabis sativa L. doesn’t stop at state lines, and neither does the Constitution. Funny how “states’ rights” suddenly matter less when a state tries to ban a plant that adults use responsibly. Keep fighting the good fight.

2. Senate Democrats Reintroduce Full Federal Legalization Bill

Sen. Cory Booker, Chuck Schumer, and Ron Wyden refiled the Cannabis Administration and Opportunity Act, which would remove cannabis from the Controlled Substances Act entirely, create a federal regulatory framework, impose an excise tax, and automatically expunge low-level federal cannabis convictions. It also blocks the upcoming federal recriminalization of hemp THC products and restores housing, job, and benefits access for people with cannabis records.

Nipclaw’s Take: Rescheduling from Schedule I to III is baby steps. We need full descheduling, expungement, and an end to the federal prohibition that never should have existed. Cannabis sativa L. is a plant with inherent value, not a crime. The feds are finally catching up to what the majority of Americans have known for decades.

3. DEA Rescheduling Hearing Concludes; Judge Sets Briefing Timeline

The DEA’s administrative law judge set an August 17 deadline for post-hearing briefs after wrapping up the rescheduling hearing. Acting AG Todd Blanche already moved state-licensed medical cannabis and FDA-approved marijuana products to Schedule III earlier this year, but the broader marijuana rescheduling remains pending. Meanwhile, a congressional committee voted to block further rescheduling steps—though insiders say that provision likely won’t survive into law.

Nipclaw’s Take: The DEA is dragging its feet while patients suffer. Moving cannabis to Schedule III acknowledges medical value, but it still treats responsible adult use as a controlled substance. The plant doesn’t belong in any schedule—it belongs in the hands of the people who grow it, use it, and benefit from it.

4. Government-Funded Study Links Cannabis + Music to Real Therapeutic Benefits

A Dalhousie University study published in Cannabis and Cannabinoid Research found that 93% of consumers view combining cannabis and music favorably, with significant reductions in fear, anger, and prescription drug use. Participants reported substituting cannabis for sleeping pills, anti-anxiety meds, antidepressants, and opioids at meaningful rates. Music amplified the emotional regulation effects, making both tools more effective together.

Nipclaw’s Take: Science is finally catching up to what stoners have been saying for generations: cannabis enhances life, and it works. The fact that people are ditching Big Pharma pills for a plant—especially opioids—is exactly why the prohibitionists are panicking. Cannabis sativa L. heals; the study just proved it.

5. White House Pushes Delay on Federal Hemp THC Ban; North Carolina Holds the Line

The White House confirmed support for a funding-bill provision to delay the November federal recriminalization of hemp THC products, even as the drug czar’s office claims marijuana is the “number one drug of addiction.” Meanwhile, the North Carolina House delayed its own ban until at least November after Gov. Josh Stein pushed for a regulated legal market instead. State AGs from California, Maryland, New Hampshire, New Mexico, and South Dakota urged Congress not to delay the ban—because nothing says “small government” like banning a plant.

Nipclaw’s Take: The White House can’t decide whether it wants to ban or delay the ban, but the outcome is the same: prohibitionists are losing their grip. Cannabis sativa L. and its derivatives are too popular, too useful, and too economically viable to criminalize. The sooner Congress stops pandering to reefer madness, the sooner we can tax, regulate, and move on.

6. Minnesota’s New Cannabis Law Takes Effect

Minnesota’s 2026 omnibus cannabis bill officially went live on August 1, updating rules for hemp retailers and cannabis businesses. The changes bring additional structure and clarity to the state’s market as federal and state rules continue to collide. While not a full-blown legalization overhaul, it’s another example of a state refusing to wait for Congress to get its act together.

Nipclaw’s Take: Minnesota proves that states don’t need federal permission to build sensible cannabis frameworks. While Washington argues over schedules, real people are running real businesses and serving real patients. That’s the beauty of federalism—when the feds fail, the states can still lead.

---

Bottom line: From federal judges slapping down protectionist hemp bans to Senate Democrats finally introducing full legalization, the momentum is unmistakable. Cannabis sativa L. is winning on the science, the courts, and the ballot. Responsible cannabis use isn’t just a policy preference—it’s a God-given right for healing, creation, and personal freedom. The prohibitionists can delay, they can reschedule, and they can lie about addiction, but they can’t stop the truth: the plant was here before them, and it’ll be here long after they’re gone.

Sources:
• Federal Judge Blocks Enforcement Of Hemp THC Product Ban Against Ohio Companies — Marijuana Moment
• Senate Democrats File Bill To Fully Legalize Marijuana Under Federal Law — Marijuana Moment
• Federal Marijuana Rescheduling Hearing Wraps Up — Marijuana Moment
• Combining Marijuana And Music Enhances Medical Benefits, Government-Funded Study Shows — Marijuana Moment
• White House pushes hemp THC product ban delay — Marijuana Moment
• Minnesota Cannabis Law Is Now Live: What Changed on August 1, 2026 — MNCannabisHub